Inicio > BIGG > Resultado de la búsqueda

    Resultados: 2

    The advisory committee on immunization practices’ recommendation for use of Moderna COVID-19 vaccine in adults aged ≥18 years and considerations for extended intervals for administration of primary series doses of mRNA COVID-19 vaccines: United States, february 2022

    Wallace, Megan; Moulia, Danielle; Blain, Amy E; Ricketts, Erin K; Minhaj, Faisal S; Link-Gelles, Ruth; Curran, Kathryn G; Hadler, Stephen C; !Asif, Amimah; Godfrey, Monica; Hall, Elisha; Fiore, Anthony; Meyer, Sarah; Su, John R; Weintraub, Eric; Oster, Matthew E; Shimabukuro, Tom T; Campos-Outcalt, Doug; Morgan, Rebecca L; Bell, Beth P; Brooks, Oliver; Talbot, H. Keipp; Lee, Grace M; Daley, Matthew F; Oliver, Sara E.
    MMWR recomm. rep; 71 (11), 2022
    The mRNA-1273 (Moderna) COVID-19 vaccine is a lipid nanoparticle-encapsulated, nucleoside-modified mRNA vaccine encoding the stabilized prefusion spike glycoprotein of SARS-CoV-2, the virus that causes COVID-19. During December 2020, the vaccine was granted Emergency Use Authorization (EUA) by the Food a...
    Vacuna nCoV-2019 mRNA-1273/inmunología, Vacuna nCoV-2019 mRNA-1273/administración & dosificación, Programas de Inmunización/normas, COVID-19/prevención & control
    Texto completo

    Use of the Janssen (Johnson & Johnson) COVID-19 vaccine: updated interim recommendations from the advisory committee on immunization practices: United States, December 2021

    Oliver, Sara E; Wallace, Megan; See, Isaac; Mbaeyi, Sarah; Godfrey, Monica; Hadler, Stephen C; Jatlaoui, Tara C; Twentyman, Evelyn; Hughes, Michelle M; Rao, Agam K; Fiore, Anthony; Su, John R; Broder, Karen R; Shimabukuro, Tom; Lale, Allison; Shay, David K; Markowitz, Lauri E; Wharton, Melinda; Bell, Beth P; Brooks, Oliver; McNally, Veronica; Lee, Grace M; Talbot, H. Keipp; Daley, Matthew F.
    MMWR recomm. rep; 71 (3), 2022
    On February 27, 2021, the Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the adenovirus-vectored COVID-19 vaccine (Janssen Biotech, Inc., a Janssen Pharmaceutical company, Johnson & Johnson), and on February 28, 2021, the Advisory Committee on Immunization Practices (A...
    Trombosis/complicaciones, Ad26COVS1/efectos adversos, Programas de Inmunización/normas, COVID-19/prevención & control, Síndrome de Guillain-Barré/complicaciones
    Texto completo